Economics of Self-Measured Blood Pressure Monitoring: A Community Guide Systematic Review
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Context The health and economic burden of hypertension, a major risk factor for cardiovascular disease, is substantial. This systematic review evaluated the economic evidence of self-measured blood pressure (SMBP) monitoring interventions to control hypertension. Evidence acquisition The literature search from database inception to March 2015 identified 22 studies for inclusion with three types of interventions: SMBP used alone, SMBP with additional support, and SMBP within team-based care (TBC). Two formulae were used to convert reductions in systolic BP (SBP) to quality-adjusted life years (QALYs) to produce cost per QALY saved. All analyses were conducted in 2015, with estimates adjusted to 2014 U.S dollars. Evidence synthesis Median costs of intervention were $60 and $174 per person for SMBP alone and SMBP with additional support, respectively, and $732 per person per year for SMBP within TBC. SMBP alone and SMBP with additional support reduced healthcare cost per person per year from outpatient visits and medication (medians $148 and $3, respectively; median follow-up, 12–13 months). SMBP within TBC exhibited an increase in healthcare cost (median, $447 per person per year; median follow-up, 18 months). SMBP alone varied from cost saving to a maximum cost of $144,000 per QALY saved, with two studies reporting an increase in SBP. The two translated median costs per QALY saved were $2,800 and $4,000 for SMBP with additional support and $7,500 and $10,800 for SMBP within TBC. Conclusions SMBP monitoring interventions with additional support or within TBC are cost effective. Cost effectiveness of SMBP used alone could not be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parati, G., Stergiou, G. S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., Kario, K., Lurbe, E., Manolis, A., Mengden, T., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328308da66 · Cited by 837 · cited 1×
“52 The change in healthcare cost also included savings from identifying patients with white coat hypertension and taking some patients off medication, even as benefits of treating white coat hypertension are still debated.”
BackgroundLackland, D. T., Roccella, E. J., Deutsch, A. F., Fornage, M., George, M. G., Howard, G., Kissela, B. M., Kittner, S. J., Lichtman, J. H., Lisabeth, L. D., et al. (2014) · Stroke · doi:10.1161/01.str.0000437068.30550.cf · Cited by 815
Self-citationAssessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
Margolis, K. L., Asche, S. E., Bergdall, A. R., Dehmer, S. P., Groen, S. E., Kadrmas, H. M., Kerby, T. J., Klotzle, K. J., Maciosek, M. V., Michels, R. D., et al. (2013) · JAMA · doi:10.1001/jama.2013.6549 · Cited by 591
Hodgkinson, J., Mant, J., Martin, U., Guo, B., Hobbs, F. D. R., Deeks, J. J., Heneghan, C., Roberts, N., & McManus, R. J. (2011) · BMJ · doi:10.1136/bmj.d3621 · Cited by 370 · cited 1×
“…interventions was on treatment and management of high BP, this economic review also recognizes the diagnostic function of home BP monitors because identification of “white coat hypertension” and masked hypertension 18,9 in a population can have substantial implications for healthcare resource use.”
BackgroundUhlig, K., Patel, K., Ip, S., Kitsios, G. D., & Balk, E. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-3-201308060-00008 · Cited by 368 · cited 4×
“Although the focus of the Agency for Healthcare Research and Quality effectiveness review 5,6 of SMBP interventions was on treatment and management of high BP, this economic review also recognizes the diagnostic function of home BP monitors because identification of “white coat hypertension” and…”
BackgroundMethodInfluentialLovibond, K., Jowett, S., Barton, P., Caulfield, M., Heneghan, C., Hobbs, F. R., Hodgkinson, J., Mant, J., Martin, U., Williams, B., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61184-7 · Cited by 311 · cited 1×
“10 Figure 1 depicts the intervention, the population, and transitions in health status ascribed to the intervention (Intervention Effectiveness), below which appear associated resource use and economic benefits (Economic Outcomes).”
BackgroundStaessen, J. A. (2004) · JAMA · doi:10.1001/jama.291.8.955 · Cited by 288 · cited 3×
“Two studies 23,29 of SMBP alone showed that SBP decreased following intervention and that averted healthcare cost exceeded intervention cost, whereas three studies 22,24,27,30,31 indicated SMBP alone was not cost effective.”
BackgroundResultParati, G., Omboni, S., Albini, F., Piantoni, L., Giuliano, A., Revera, M., Illyes, M., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283163caf · Cited by 166
Arrieta, A., Woods, J. R., Qiao, N., & Jay, S. J. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03780 · Cited by 75
Economic evaluation of telephone self-management interventions for blood pressure control
Wang, V., Smith, V. A., Bosworth, H. B., Oddone, E. Z., Olsen, M. K., McCant, F., Powers, B. J., & Van Houtven, C. H. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.03.016 · Cited by 49 · cited 4×
“Median cost per QALY saved for SMBP within TBC was $7,500 and $10,800, respectively, for the two translation methods, based on six estimates from four 22,27,33,41,42,44,49 studies.”
BackgroundMethodInfluential
Cited by
Shimbo, D., Artinian, N. T., Basile, J. N., Krakoff, L. R., Margolis, K. L., Rakotz, M. K., Wozniak, G., & On behalf of the American Heart Association and the American Medical Association (2020) · Circulation · doi:10.1161/cir.0000000000000803 · Cited by 389
Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global Evidence
Kario, K., Shimbo, D., Hoshide, S., Wang, J.-G., Asayama, K., Ohkubo, T., Imai, Y., McManus, R. J., Kollias, A., Niiranen, T. J., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12630 · Cited by 82
Margolis, K. L., Dehmer, S. P., Sperl-Hillen, J., O’Connor, P. J., Asche, S. E., Bergdall, A. R., Green, B. B., Nyboer, R. A., Pawloski, P. A., Trower, N. K., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15492 · Cited by 48
“The economic evidence on self-monitoring of BP has been thoroughly reviewed for the Guide to Community Preventive Services, categorized as self-monitoring of BP alone, with some support, and with team-based care.(27) Using standardized estimates of quality-adjusted life years saved per one mm Hg reduction in SBP, self…”
BackgroundMethodHayek, M. A., Giannouchos, T., Lawley, M., & Kum, H.-C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.44372 · Cited by 32
Shantharam, S. S., Mahalingam, M., Rasool, A., Reynolds, J. A., Bhuiya, A. R., Satchell, T. D., Chapel, J. M., Hawkins, N. A., Jones, C. D., Jacob, V., et al. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.06.025 · Cited by 13
“All studies that were included in CPSTF’s cost-effectiveness review were considered for inclusion.(32) The CPSTF review’s search period was from the inception of the databases to March 2015; a bridge search was conducted for this review by replicating the search strategy from the CPSTF’s cost-effectiveness review and…”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Jacob, V., Chattopadhyay, S. K., Proia, K. K., Hopkins, D. P., Reynolds, J., Thota, A. B., Jones, C. D., Lackland, D. T., Rask, K. J., Pronk, N. P., Clymer, J. M., & Goetzel, R. Z.
- Venue
- American Journal of Preventive Medicine
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 53
- Issue
- 3
- Pages
- e105-e113
- ISSN
- 0749-3797 (ISSN-L)
- OpenAlex
- W2748748932
- Cited by
- 40
- References
- 11
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.